Molecular Mechanisms of Mammalian SIRT6 Function
哺乳动物 SIRT6 功能的分子机制
基本信息
- 批准号:9118549
- 负责人:
- 金额:$ 48.68万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-09-15 至 2016-05-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAffectAgingBerylliumBiochemicalBiology of AgingCancer BiologyCancer cell lineCell AgingCell physiologyCellsCellular biologyCentromereChromatinChromatin StructureChromosomal RearrangementChromosome SegregationDNADNA RepairDNA SequenceDNA Transposable ElementsDataDeacetylaseDefectDiseaseElementsEnzymesEpigenetic ProcessEventFamilyFibroblastsFunctional disorderGene ExpressionGenesGenetic TranscriptionGenomic InstabilityGenomicsGoalsHealthHeterochromatinHomeostasisHumanHuman GenomeJunk DNALinkLongevityLysineMaintenanceMalignant NeoplasmsMammalian CellMetabolicMetabolic DiseasesMitosisMitoticModelingMolecularMusNeurodegenerative DisordersNuclearOncogenicPathogenesisPathologyPhenotypeProcessRegulationRegulator GenesRepressionResearchRoleSatellite DNASirtuinsSomatic CellTelomere MaintenanceTestingTherapeutic InterventionTissuesTranscriptTranscriptional Silencer ElementsTranslatingUntranslated RNAage relatedcancer cellfunctional declinefunctional genomicshealthy aginghuman diseaseinsightmammalian genomenovelprogramstelomeretumor metabolismtumor progression
项目摘要
DESCRIPTION (provided by applicant): Our research seeks to understand how chromatin regulatory mechanisms influence nuclear and epigenetic programs, and how de-regulation of these mechanisms contributes to aging and disease. SIRT6 is a chromatin regulatory factor in the sirtuin family of enzymes. SIRT6-deficiency in mice leads to shortened lifespan and phenotypes associated with aging, cancer, and metabolism. Conversely, SIRT6 over-expression in mice protects against metabolic disease and extends lifespan. Thus, studying SIRT6 function promises to elucidate fundamental mechanisms that underlie healthy aging and longevity. Previously, we showed that SIRT6 selectively regulates specific chromatin marks associated with epigenetic and gene-regulatory functions. We linked chromatin regulation by SIRT6 to key nuclear processes that impact on aging and cancer, including telomere maintenance, DNA repair, and aging-associated gene expression changes. Here, we focus on new functions of SIRT6 in chromatin silencing mechanisms that are deregulated in aging. We propose molecular, genomic, and functional studies to study the role of SIRT6 in maintaining heterochromatin silencing at repetitive DNA elements, and ask how impaired silencing leads to cellular dysfunction associated with aging. In Aim 1, we will study the molecular mechanisms of SIRT6 in heterochromatin silencing of repetitive satellite DNA elements at centromeres. Defects in centromeric heterochromatin are observed in the contexts of both aging and cancer. We will characterize the biochemical activity of SIRT6 at centromeric chromatin, how this is regulated during mitosis, and how it affects higher order chromatin changes. Our studies will provide insights for cancer cell biology, where SIRT6 loss may contribute to cancer progression, and for human somatic cells, where SIRT6 may guard against cellular senescence or age-dependent decline in epigenetic plasticity. In Aim 2, we will characterize the functional effects of heterochromatin maintenance by SIRT6 on cellular homeostasis. We will test the hypotheses that heterochromatin loss at centromeres triggers abnormal mitoses, chromosome segregation defects, and cellular senescence, and can facilitate the oncogenic process of cellular immortalization. We will also examine functional interplay between SIRT6 and other SIRT enzymes in these processes. These studies should elucidate how heterochromatin breakdown is translated into cellular phenotypes or functional decline that contributes to aging and disease.
In Aim 3, we will investigate the role of SIRT6 in heterochromatin maintenance at another class of repetitive DNA elements that are deregulated in aging and cancer - endogenous retrotransposable elements. We will ask if impaired silencing of these elements leads to genomic instability that can affect cellular function, or to aberrant transcription of aging- relatd genes. Together, these studies should provide insights into fundamental chromatin mechanisms in aging biology.
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Nuclear DNA damage signalling to mitochondria in ageing.
- DOI:10.1038/nrm.2016.14
- 发表时间:2016-05
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Katrin F Chua其他文献
Katrin F Chua的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Katrin F Chua', 18)}}的其他基金
BLRD Research Career Scientist Award Application
BLRD 研究职业科学家奖申请
- 批准号:
10594020 - 财政年份:2022
- 资助金额:
$ 48.68万 - 项目类别:
Histone Deacetylation Signaling in Aging and Cancer Pathways
衰老和癌症途径中的组蛋白脱乙酰化信号转导
- 批准号:
10651829 - 财政年份:2021
- 资助金额:
$ 48.68万 - 项目类别:
Histone Deacetylation Signaling in Aging and Cancer Pathways
衰老和癌症途径中的组蛋白脱乙酰化信号转导
- 批准号:
10819057 - 财政年份:2021
- 资助金额:
$ 48.68万 - 项目类别:
Histone Deacetylation Signaling in Aging and Cancer Pathways
衰老和癌症途径中的组蛋白脱乙酰化信号转导
- 批准号:
10448391 - 财政年份:2021
- 资助金额:
$ 48.68万 - 项目类别:
Molecular Mechanisms of Mammalian SIRT6 Function
哺乳动物 SIRT6 功能的分子机制
- 批准号:
9282767 - 财政年份:2016
- 资助金额:
$ 48.68万 - 项目类别:
Molecular Mechanisms of Mammalian SIRT6 Function
哺乳动物 SIRT6 功能的分子机制
- 批准号:
9107282 - 财政年份:2016
- 资助金额:
$ 48.68万 - 项目类别:
Molecular Mechanisms of Mammalian SIRT6 Function
哺乳动物 SIRT6 功能的分子机制
- 批准号:
9901411 - 财政年份:2016
- 资助金额:
$ 48.68万 - 项目类别:
MOLECULAR INTERACTIONS AND SUBSTRATES OF MAMMALIAN SIRT6 LONGEVITY REGULATOR
哺乳动物 SIRT6 寿命调节剂的分子相互作用和底物
- 批准号:
8363767 - 财政年份:2011
- 资助金额:
$ 48.68万 - 项目类别:
相似海外基金
Hormone therapy, age of menopause, previous parity, and APOE genotype affect cognition in aging humans.
激素治疗、绝经年龄、既往产次和 APOE 基因型会影响老年人的认知。
- 批准号:
495182 - 财政年份:2023
- 资助金额:
$ 48.68万 - 项目类别:
Parkinson's disease and aging affect neural activation during continuous gait alterations to the split-belt treadmill: An [18F] FDG PET Study.
帕金森病和衰老会影响分体带跑步机连续步态改变期间的神经激活:[18F] FDG PET 研究。
- 批准号:
400097 - 财政年份:2019
- 资助金额:
$ 48.68万 - 项目类别:
The elucidation of the mechanism by which intestinal epithelial cells affect impaired glucose tolerance during aging
阐明衰老过程中肠上皮细胞影响糖耐量受损的机制
- 批准号:
19K09017 - 财政年份:2019
- 资助金额:
$ 48.68万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Does aging of osteocytes adversely affect bone metabolism?
骨细胞老化会对骨代谢产生不利影响吗?
- 批准号:
18K09531 - 财政年份:2018
- 资助金额:
$ 48.68万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Links between affect, executive function, and prefrontal structure in aging: A longitudinal analysis
衰老过程中情感、执行功能和前额叶结构之间的联系:纵向分析
- 批准号:
9766994 - 财政年份:2018
- 资助金额:
$ 48.68万 - 项目类别:
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
- 批准号:
9320090 - 财政年份:2017
- 资助金额:
$ 48.68万 - 项目类别:
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
- 批准号:
10166936 - 财政年份:2017
- 资助金额:
$ 48.68万 - 项目类别:
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
- 批准号:
9761593 - 财政年份:2017
- 资助金额:
$ 48.68万 - 项目类别:
Experimental Model of Depression in Aging: Insomnia, Inflammation, and Affect Mechanisms
衰老过程中抑郁症的实验模型:失眠、炎症和影响机制
- 批准号:
9925164 - 财政年份:2016
- 资助金额:
$ 48.68万 - 项目类别:
Experimental Model of Depression in Aging: Insomnia, Inflammation, and Affect Mechanisms
衰老过程中抑郁症的实验模型:失眠、炎症和影响机制
- 批准号:
9345997 - 财政年份:2016
- 资助金额:
$ 48.68万 - 项目类别:














{{item.name}}会员




